FDA Person
FDARuben C. Ayala
View detailed information about Ruben C. Ayala, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 27 inspections of 27 companies, 2016–2026.
Inspections (27)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| April 17, 2026 | Novo Nordisk A/S - G8, X9 M.FI | Not classified | #1316850 | |
| April 10, 2026 | Hanlim Pharm Co., Ltd. | Not classified | #1316122 | |
| February 6, 2026 | Shanghai Xihua Scientific Co. Ltd. | NAI | Bioresearch Monitoring | #1305450 |
| January 30, 2026 | Labcorp Development (Asia) Pte. Ltd | Not classified | #1305006 | |
| September 5, 2025 | Janssen Pharmaceutica, N.V. | Not classified | #1270321 | |
| August 29, 2025 | SGS France Life Sciences | Not classified | #1283498 | |
| May 22, 2025 | Chengdu Shuode Pharmaceutical Co., Ltd | Not classified | #1278226 | |
| May 15, 2025 | FRONTAGE LABORATORIES SHANGHAI CO. | NAI | Bioresearch Monitoring | #1274577 |
| May 9, 2025 | Frontage Laboratories (Suzhou) Co.,Ltd. | Not classified | #1278466 | |
| January 17, 2025 | Laboratorios Liconsa SAU | Not classified | #1251910 | |
| January 10, 2025 | Quinta Analytica s.r.o. | Not classified | #1260984 | |
| August 2, 2024 | Sindan-Pharma SRL | NAI | Bioresearch Monitoring | #1247794 |
| July 26, 2024 | Lek Pharmaceuticals | NAI | Bioresearch Monitoring | #1246916 |
| May 10, 2024 | VerGo Pharma Research Pvt., Ltd | NAI | Bioresearch Monitoring | #1259998 |
| May 3, 2024 | Alphapharm Pty, Ltd. | NAI | Bioresearch Monitoring | #1236816 |
| October 27, 2023 | LabAnalysis Life Science S.R.L. | OAI | Bioresearch Monitoring | #1223861 |
| September 29, 2023 | Glenmark Pharmaceuticals Ltd. | NAI | Bioresearch Monitoring | #1220575 |
| September 20, 2019 | Sitec Labs Limited | VAI | Bioresearch Monitoring | #1110281 |
| September 13, 2019 | Watson Pharma Private Ltd. | NAI | Bioresearch Monitoring | #1109471 |
| April 27, 2018 | Avant Sante Research Center S.A. de C.V. | NAI | Bioresearch Monitoring | #1054409 |
Documents (9)
- EIR · Alcami Carolinas Corporation · December 6, 2024
- 483 · GLPGCP Development (Asia) Pte. Ltd. · January 30, 2026
- 483 · Janssen Pharmaceutica, N.V. · September 5, 2025
- 483 · SGS France · August 29, 2025
- 483 · Laboratorios Liconsa SAU · January 17, 2025
- EIR · Integris Bioservices LLC · June 24, 2016
- 483 · Novo Nordisk A/S - G8, X9 M.FI · April 17, 2026
- EIR · Merck & Co Inc · June 14, 2013
- 483 · LabAnalysis Life Science S.R.L.
Frequently inspected with (8)
Young M. Choi
investigator
4 shared
Li-Hong P. Yeh
3 shared
Nicola M. Fenty-Stewart
3 shared
Li-Hong Yeh
2 shared
Xingfang Li
2 shared
Janet B. Abt
investigator
1 shared
Mark W. Babbitt
1 shared
Sri Rama Kr Yellela
1 shared
Person Information
Name
Ruben C. Ayala
Title
investigator
Role
COMPANY REP
ID: 6b5dadad-56b8-4af0-a65f-4685f71f0c8d
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.